Follow
Mehmet Sofuoglu
Mehmet Sofuoglu
Verified email at yale.edu
Title
Cited by
Cited by
Year
Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
M Sofuoglu, PS Portoghese, AE Takemori
Journal of Pharmacology and Experimental Therapeutics 257 (2), 676-680, 1991
4351991
The effect of cannabis compared with alcohol on driving
RA Sewell, J Poling, M Sofuoglu
American journal on addictions 18 (3), 185-193, 2009
4172009
Cognitive enhancement as a treatment for drug addictions
M Sofuoglu, EE DeVito, AJ Waters, KM Carroll
Neuropharmacology 64, 452-463, 2013
3192013
Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans.
M Sofuoglu, S Dudish-Poulsen, D Nelson, PR Pentel, DK Hatsukami
Experimental and clinical psychopharmacology 7 (3), 274, 1999
2891999
Stress decreases the ability to resist smoking and potentiates smoking intensity and reward
SA McKee, R Sinha, AH Weinberger, M Sofuoglu, ELR Harrison, ...
Journal of psychopharmacology 25 (4), 490-502, 2011
2812011
Neuroscience of behavioral and pharmacological treatments for addictions
MN Potenza, M Sofuoglu, KM Carroll, BJ Rounsaville
Neuron 69 (4), 695-712, 2011
2602011
Norepinephrine and stimulant addiction
M Sofuoglu, RA Sewell
Addiction biology 14 (2), 119-129, 2009
2052009
Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population
J Poling, A Oliveto, N Petry, M Sofuoglu, K Gonsai, G Gonzalez, B Martell, ...
Archives of general psychiatry 63 (2), 219-228, 2006
2042006
Cognitive enhancement as a pharmacotherapy target for stimulant addiction
M Sofuoglu
Addiction 105 (1), 38-48, 2010
1822010
Novel approaches to the treatment of cocaine addiction
M Sofuoglu, TR Kosten
CNS drugs 19 (1), 13-25, 2005
1572005
Treatment outcome predictors for cocaine dependence
J Poling, TR Kosten, M Sofuoglu
The American journal of drug and alcohol abuse 33 (2), 191-206, 2007
1452007
The drug effects questionnaire: psychometric support across three drug types
ME Morean, H de Wit, AC King, M Sofuoglu, SY Rueger, SS O’Malley
Psychopharmacology 227 (1), 177-192, 2013
1442013
Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study
G Gonzalez, K Sevarino, M Sofuoglu, J Poling, A Oliveto, K Gonsai, ...
Addiction 98 (11), 1625-1632, 2003
1352003
Effects of progesterone treatment on smoked cocaine response in women
M Sofuoglu, DA Babb, DK Hatsukami
Pharmacology Biochemistry and Behavior 72 (1-2), 431-435, 2002
1322002
Cognitive effects of nicotine: recent progress
G Valentine, M Sofuoglu
Current neuropharmacology 16 (4), 403-414, 2018
1292018
Role of progesterone in nicotine addiction: evidence from initiation to relapse.
WJ Lynch, M Sofuoglu
Experimental and clinical psychopharmacology 18 (6), 451, 2010
1272010
Emerging pharmacological strategies in the fight against cocaine addiction
M Sofuoglu, TR Kosten
Expert opinion on emerging drugs 11 (1), 91-98, 2006
1242006
Effects of progesterone treatment on cocaine responses in male and female cocaine users
M Sofuoglu, E Mitchell, TR Kosten
Pharmacology Biochemistry and Behavior 78 (4), 699-705, 2004
1242004
7-Benzylidenenaltrexone (BNTX): a selective δ1 opioid receptor antagonist in the mouse spinal cord
M Sofuoglu, PS Portoghese, AE Takemori
Life sciences 52 (8), 769-775, 1993
1171993
The impact of cigarette smoking on stimulant addiction
AH Weinberger, M Sofuoglu
The American journal of drug and alcohol abuse 35 (1), 12-17, 2009
1152009
The system can't perform the operation now. Try again later.
Articles 1–20